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Background: Heightened public awareness about Alzheimer’s disease and dementia
increases the need for at-home cognitive self-testing. We offered Cognitive Online
Self-TestAmsterdam (COST-A) to independent groups of cognitively normal adults and
investigated the robustness of a norm-score formula and cutoff.
Methods: Three thousand eighty-eight participants (mean age ± standard deviation
= 61 ± 12 years, 70% female) completed COST-A and evaluated it. Demographically
adjusted norm scoreswere the difference between expected COST-A scores, based on
age, gender, and education, and actual scores.Weapplied the resulting norm-score for-
mula to two independent cohorts.
Results: Participants evaluated COST-A to be of adequate difficulty and duration. Our
norm-score formula was shown to be robust: ≈8% of participants in two cognitively
normal cohorts had abnormal scores. A cutoff of -1.5 standard deviations proved opti-
mal for distinguishing normal from impaired cognition.
Conclusion: With robust norm scores, COST-A is a promising new tool for research
and clinical practice, providing low cost and minimally invasive remote assessment of
cognitive functioning.
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1 INTRODUCTION
Early detection of Alzheimer’s disease (AD) is essential for timely
and adequate patient management, as well as for maximizing the
benefit of potential disease-modifying treatment and other preven-
tive efforts.1 Likewise, easily accessible assessment of cognition has
become increasingly relevant, with initiatives to raise public awareness
about AD and other forms of dementia having heightened the vigilance
for cognitive decline among the general public. This has left many con-
cerned, yet non-demented, individuals in needof reassurance, informa-
tion, and advice.2–4 Furthermore, many people, and elderly in partic-
ular, experience physical, social, and psychological barriers hindering
them fromvisiting their general practitioner or amemory clinic.5,6 Con-
sequently, many cases of imminent dementia remain undetected until
later disease stages.7,8
Online testing could help to overcome these barriers, not in the
least because of its flexibility in time and location, that is, the poten-
tial of self-administration at home.9 The relevance of self-testing in the
safety of one’s own home is emphasized by the coronavirus disease
2019 (COVID-19) pandemic, which has impacted the availability and
provision of face-to-face care to memory clinic patients.10,11 Cogni-
tive online self-testing removes the psychological obstacles associated
with visiting a doctor or clinic and is low-cost. Nevertheless, despite
its potential value, there are only a few online self-tests of cognitive
functioning available to date (one example: the Amsterdam Cognition
Scan12).
We previously developed an online self-administered test of
cognitive functioning: the Cognitive Online Self-Test Amsterdam
(COST-A), based on the Telephonic Remote Evaluation of Neu-
ropsychological Deficits (TREND).13 The content of the TREND was
expanded by including visual and visuospatial tasks, resulting in a
battery of 10 tasks measuring various cognitive abilities.14 In a first
validation study,14 we tested the convergent validity and diagnostic
accuracy of COST-A for mild cognitive impairment (MCI) and demen-
tia in amemory clinic setting and found strong associationswith paper-
and-pencil cognitive tests, namely, the Mini-Mental State Examination
(MMSE) (correlation coefficient r = .64) and neuropsychological tests
for memory (r = .71), executive functioning (r = .57), and attention
(r= .5).14 COST-Aalsohadadequatediagnostic accuracy indistinguish-
ingMCI and dementia from cognitively normal individuals.14
The ultimate goal of COST-A is to enable community-dwelling
older adults to self-assess their cognitive functioning and to pro-
mote early detection of cognitive decline in the context of AD and
dementia. To better interpret COST-A performance of community-
dwelling adults, representative normative data from online, self-
administered, home assessment are required. Such data should
be adjusted for age, education, and gender, as these factors are
often found to be associated with cognitive performance in aging
individuals.15
In this study, we collected COST-A data in a large, community-
dwelling sample of adults to establish a formula for calculating
demographically adjusted, standardized norm scores, and collect user
experiences. In addition, we applied these norm scores in independent
Research in Context
1. Systematic review: Online cognitive self-testing is a fairly
novel practice. We reviewed results from a PubMed
search and found that little is currently known about the
usability and quality of online cognitive self-tests, and
that normative data are mostly lacking. We previously
developed an online self-administered test of cognitive
functioning: the Cognitive Online Self-Test Amsterdam
(COST-A).
2. Interpretation: Our current study provides demographi-
cally adjusted normative data for COST-A, a new cogni-
tive self-assessment tool for research and clinical prac-
tice. This allows for substantive interpretation of test
results and comparison to cognitively normal individuals.
3. Future directions: Improving communication about test
results is an important avenue for future research. Fur-
thermore, the predictive quality and usability of COST-
A for the measurement of disease progression should be
investigated in longitudinal studies.
samples of cognitively normal adults and patients diagnosed with MCI
andmild dementia, to investigate their robustness.
2 METHODS
2.1 Study design
We recruited adults via the Dutch Brain Research Registry, an
online platform for people interested in participating in brain-related
research.16 Data collection ran from August 2018 to December 2018
and was approved by the medical ethical committee of the VU Univer-
sityMedical Center. Participants provided consent via the Dutch Brain
Research Registry.
Registrants who indicated their interest in participation were
invited by e-mail to an online portal that hosted the cognitive test. Par-
ticipantswho did not respondwere reminded two and fourweeks after
their first invitation, aswell as approximately twoweeksbefore the end
of data collection.
2.2 Participants and procedures
We invited individuals 18 years or older who had a good command of
theDutch language. Individualswho reported a dementia-related diag-
nosis (ie, dementia orMCI) were excluded.
The inclusion flow chart of the study is shown in Figure 1. At the
time of recruitment, 11,060 registrants of the Dutch Brain Research
Registry were eligible and invited to participate in this study by email.
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F IGURE 1 Flow chart of participant inclusion. Note: Of all
participants who started with the COST-A (N= 3529), 441 (12%) did
not successfully complete all subtasks or were excluded based on
invalid data, eg, because of technical issues.We used a t test for age
and chi-square test for gender and education level to analyze
differences in demographics between participants included in the
norm sample (N= 3088) and those who started but were excluded
(N= 441).The sample of excluded participants did not differ from the
norm sample with respect to the distributions of gender (70% female,
P= .183) or education level (65% high, P= .133), but excluded
participants were significantly older (P< .001), with amean age of 64
years (SD= 13). Abbreviations: COST-A, Cognitive Online Self-Test
Amsterdam; TMT, Trail-Making Test
Of these, 4817 (44%) declared their interest. Complete and valid data
were available from 3088 (64%). We refer to these 3088 participants
as our “norm sample.”
2.3 Measures
2.3.1 Sample characteristics
Participants self-reported their age, gender, and level of education.We
dichotomized education level into low–medium (up to the equivalent
of high school education) and high education (the equivalent of college
education).
2.3.2 Cognitive Online Self-Test Amsterdam
(COST-A)
TheCognitiveOnline Self-TestAmsterdam (COST-A)was developedby
VanMierlo et al.14 COST-Awas designed to be completed on a desktop
or laptop computer, was hosted online by Neurotask, and was accessi-
ble via a personalized link to their website. Prior to starting COST-A,
participantswere instructed to (1) find a placewith quiet surroundings,
(2) reserve at least 20minutes to completeCOST-A in one go, and (3) to
not use any aids, such as a calendar, clock, pen, or paper. COST-A takes
approximately 20minutes to complete and includes 10 cognitive tasks:
orientation (score 0-5), digit-sequence learning (score 0-3), immediate
word recall (score 0-10), two trail-making tasks (A: connecting num-
bered dots, and B: alternately connecting lettered and numbered dots;
score 0-300, indicating seconds to complete the task), delayed word
recall (score 0-10), delayed word recognition (score 0-20), word pairs
immediate recall (score 0-20), word pairs recognition (score 0-10), and
semantic comprehension (score 0-6).
Raw scores on all subtaskswere converted into standardized scores
(Z-scores:mean 0, SD1). Trail-making test scoreswere reverse-scored,
so that higher scores represented better performance. The subtask Z-
scores were then averaged into a composite score representing over-
all cognitive functioning. The resulting mean composite score is 0, with
scores above 0 indicating better cognitive performance, and scores
below 0 indicating poorer cognitive performance. Actual duration, that
is, the time it took to complete all subtasks of theCOST-A, is registered
automatically.
2.3.3 Additional measures
A single yes-or-no question assessed whether the participant experi-
enced memory complaints. Depressive symptoms of participants were
assessed with the five-item short form of the Geriatric Depression
Scale (GDS-5),17 which was administered online after completion of
COST-A. Scores ranged from 0 to 5, with higher scores indicating
more depressive symptoms. GDS-5 total scores were dichotomized
into absence (total score of 0) or presence of depressive symptoms
(total score of 1 or higher).
In addition, participants answered questions about their experi-
ences during the completion of COST-A, including items evaluating
difficulty, enjoyment, and duration of COST-A, and clarity of test
instructions. Furthermore, four items assessed encountered comple-
tion issues: presence or absence of problemswith vision, input (regard-
ing the use of keyboard andmouse), interruptions, and whether partic-
ipants perceived their surroundings as quiet, neutral, or noisy.
2.4 Analyses
Analyses were performed in IBM SPSS version 2618 and R version
4.0.3.19
2.4.1 Demographically adjusted norm score
formula
Before calculating a norm score formula, outliers on the composite
Z-score (≤ -3 or ≥ 3) were identified and excluded from data analy-
sis to limit the influence of extreme scores. In regression analyses, we
then regressed the composite cognition score on the predictive demo-
graphic variables age, gender (0 = male, 1 = female), and education
(0= low/medium, 1= high), first in separate models, and then in a mul-
tiple regression model combining all demographic variables that were
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significant predictors. The calculationof thenormscores is shownstep-
by-step below:
1. Compute the actual COST-A composite score by averaging subtask
Z-scores using themeans and SDs of the entire norm sample.
2. Use the coefficients from the multiple regression model containing
significant demographic variables to compute an expected COST-A
composite score.
3. Subtract the expected composite score from the actual composite
score to obtain a difference score.
4. Standardize the difference score by dividing it by the residual stan-
dard error from the multiple regression model to obtain a demo-
graphically adjusted norm score.
Wepredetermined that a demographically adjusted norm scorewas
abnormal if it was ≤ -1.5. Distributions of the scores obtained in the
four steps above are shown in the SupplementaryMaterial.
2.4.2 Self-reported problems and user experiences
Descriptives were obtained for actual test duration, self-reported
memory problems, depressive symptoms, encountered problems, and
evaluation items. Using linear regression, we assessed the predictive
value of self-reported memory problems and depressive symptoms
on demographically adjusted COST-A norm scores. Next, we tested
the influence of self-reported problems during COST-A completion on
demographically adjusted norm scores.
2.4.3 External validation of the COST-A norm
score formula
We used two other data sets to validate our demographically adjusted
norm scores and cutoff. First, of 2777 individuals who participated in
the Nijmegen Exercise Study,20 we selected 2440 individuals who did
not have a dementia-related diagnosis andwho successfully completed
COST-A between June and November 2018. These individuals com-
prise our “validation sample,” aswe consider them to represent a group
of cognitively normal adults similar to our norm sample. Second, we
selected 67 patients diagnosed with MCI or dementia from a previous
sample recruited at the Alzheimer Center Amsterdam between Febru-
ary andOctober 2015.14 This group comprised our “clinical sample.” In
both these samples, participants completed COST-A at home without
direct supervision of study personnel.
In both samples we computed the demographically adjusted norm
scores as described earlier, using the formula based on our norm
sample. We applied the −1.5 SD cutoff to calculate the percentage of
individuals who had a score below the mean. Finally, we calculated the
optimal cutoff for distinguishing cognitively normal participants from
personswithMCI or dementia based on the highest Youden index, rep-
resenting the optimal balance between specificity and sensitivity, to
compare with our predetermined cutoff.





1. Orientation 4.71 0.51 2 5
2. Digit-sequence
learning
2.73 0.59 0 3
3. Immediate
word recall








66.45 30.08 20.41 296.56
6. Free delayed
word recall
5.28 2.20 0 10
7. Delayedword
recognition




12.06 4.24 0 20
9.Word pairs
recognition
9.25 1.29 0 10
10. Semantic
comprehension
5.79 0.50 2 6
Tasks 4 and 5 are scored as seconds needed to complete; all other tasks are
scored as number of correct responses. Tasks 4 and 5 are reverse scored
before being standardized for the composite score.
3 RESULTS
3.1 Sample characteristics
A total of 3088 individuals (60.6 ± 12.1 years old, range 18-96 years;
70.0% female; 68.2% highly educated) completed COST-A. Age distri-
butions stratified by gender and education level can be found in the
Supplementary Material. It took the participants on average 17 min-
utes (SD = 6 minutes) to complete COST-A. Table 1 presents descrip-
tive statistics of raw scores of the 10 COST-A subtasks for the norm
sample.
3.2 Demographically adjusted composite score
formula
The regressionmodels, presented in Table 2, provide regression-based
normative data. The betas show that higher age, male gender, and
low/medium education level significantly deteriorated composite cog-
nition scores, both in separate linear regressions models, as well as in
a multiple linear regression model including all demographic variables
(all P< .001).
Box 1 illustrates the four steps required to obtain the demograph-
ically adjusted norm scores. After computing the COST-A composite
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TABLE 2 Regression-based normative data




regressions Age −0.019 [−0.020,−0.017] 0.502
Gender 0.215 [0.173, 0.256] 0.540
Education 0.338 [0.298, 0.378] 0.526
Multiple
regression Constant 0.666 [0.563, 0.769] 0.479
Age −0.016 [−0.018,−0.015]
Gender 0.158 [0.120, 0.195]
Education 0.296 [0.260, 0.333]
Age is entered into the models as age in years; gender as 0 = male,
1= female; education as 0= low/medium, 1= high.
Abbreviations: CI, confidence interval; SD, standard deviation.
score, the intercept and unstandardized betas derived from the mul-
tiple regression model provided the following formula for calculating
the expected composite score: 0.666 - 0.016*Age (years)+ 0.158*Gen-
der (0=male, 1= female)+0.296*Education (0= low/medium, 1= high).
The difference between the expected and actual COST-A composite
score is divided by the residual standard error from the multiple linear
regression model (0.479) to obtain a demographically adjusted, stan-
dardized norm score. In our norm sample, 242 individuals (7.8%) had a
norm score below the cutoff of−1.5 SD.
3.3 Self-reported problems and user experiences
In the norm sample, self-reported memory problems (reported by
47.3%) and depressive symptoms (M = 0.6, SD = 1.0, range = 0-5,
34.2% with score 1 or higher) were associated with cognitive func-
tioning. Participantswho reportedmemoryproblemsperformedworse
(P < .001) on COST-A (demographically adjusted norm score = -
0.16±1.06) than participants who did not report problems (0.15 ±
0.92). In addition, their scores were more often below the cutoff
(11.3%) than participants who reported no memory problems (4.7%;
χ2(1) = 45.36, P < .001). Patients who reported depressive symptoms
had lower cognitive functioning (−0.06± 0.61) than those who did not
(0.03±0.51;P< .001). The scores of participantswho reporteddepres-
sive symptomsmore often fell below the cutoff (11.4%) than the scores
of participants who did not (6.0%; χ2(1)= 27.46, P< .001).
Table 3 displays data regarding participants’ experiences with
COST-A. Overall, participants’ evaluations of the test and test instruc-
tions were positive; only a few reported the test to be difficult (7%),
dreadful (1%), or long (2%), or the instructions unclear (< 1%).
Small proportions of the norm sample reported to have experienced
problemswith vision (1%) or themouse/keyboard (4%), or to have com-
pleted the test in a noisy environment (2%). In addition, a larger per-
centage of participants reported to have been interrupted (13%) at
some point during the test (Table 3). Participants who reported any



















Vision problems 24 (0.8)






*Data available fromN= 3075.
Of note, all eight evaluation itemswere completed by the norm sample only:
participants who successfully completed all subtasks of COST-A.
of these difficulties had lower norm scores (−0.22 ± 1.0) than those
who did not encounter any difficulties (0.05 ± 0.99; P < .001). Partici-
pants who encountered problemswere alsomore likely to score below
the cutoff (10.7%) than participants who did not (7.2%; χ2(1) = 7.11,
P = .008). Of note, when participants were interrupted (the most fre-
quently reported problem), they performed worse on COST-A (−0.20
± 1.00 vs 0.03 ± 1.00, P < .001;) but their scores were not more often
below the cutoff (10.0%) than those who were not interrupted (7.5%
below cutoff, χ2(1)= 2.94, P= .086).
3.4 Validation of norm-score formula in
independent samples
The validation sample comprised 2440 community-dwelling individu-
als (mean age 58.7± 12.7 years, 43.1% female, 54.4%highly educated).
Compared to our original norm sample, individuals included in the val-
idation sample were younger, more likely to be male, and less likely to
be highly educated (all P’s< .001).
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Box 1
Formula demographically adjusted composite score= 0.666 - 0.016*Age+ 0.158*Gender+ 0.296*Education
Gender: 0=male, 1= female; Education: 0= low/medium, 1= high
Example: A 63-year-old, highly educated woman has the following raw scores, corresponding Z-scores, and actual composite score:
Task Raw score Z-scorea
1. Orientation 5 0.57
2. Digit span forward 3 0.46
3. Immediate word recall 5 −0.65
4. Connecting numbered dots (TMT-A) in sec 45 −0.41b
5. Letter number alternation (TMT-B) in sec 75 −0.28b
6. Delayedword recall (free recall) 5 −0.13
7. Delayedword recognition 18 −0.42
8.Word pairs immediate recall 11 −0.25
9.Word pairs recognition 8 −0.97
10. Semantic comprehension 5 −1.58
Actual composite score (z-score average) −0.37
aComputed using this formula: (Raw score-M)/SD;M and SD values provided in Table 2.
bZ-score inverted (multiplied by -1)
Expected composite score (following formula): 0.666 - 0.016*63+ 0.158*1+ 0.296*1= 0.11
Difference score (−0.37-0.11):−0.48
Norm score (difference score/SD residual): −0.48/0.479 = -1.00. She scores above the -1.5SD cutoff. Since this is a standardized norm
score (following a normal data distribution), a score of -1 means that 16% of women similar to her in age and education level performed
the same or worse.
What if this woman is age 40, instead of 63? Then her expected composite score becomes 0.48, the difference score −0.85 and her norm
score −1.77. This score is abnormal, considering our −1.5 cutoff. Only 4% of women similar to her in age and education level performed
the same or worse.
Using the demographically adjusted norm score formula obtained
from the original norm sample, norm scores were calculated for the
validation sample. One hundred eighty-six individuals (7.6%) from
the validation sample had a demographically adjusted norm score
of≤−1.5.
We subsequently included a sample of 67 memory clinic patients
(65.0 ± 7.3 years of age, 71.6% female, 37.3% highly educated), with
syndrome diagnoses of MCI (n = 28) or dementia (n = 39). Compared
to the norm sample, both clinical groups performed worse on COST-
A (MCI: −1.64, 95%confidence interval [CI] −1.86, −1.43; dementia:
−2.32, 95%CI −2.50, −2.15). Based on our predetermined cutoff of
−1.5SD, 21 MCI patients (75.0%) and 32 dementia patients (82.1%)
had abnormal COST-A scores. With a maximized Youden index, the
optimal cutoff on the demographically adjusted norm score for dis-
tinguishing cognitively normal individuals from cognitively abnormal
(MCI or dementia)was−1.5 (accuracy=91.6%, sensitivity= .81, speci-
ficity= .91).
Figure 2 shows the distribution of COST-A demographically
adjusted norm scores in the separate cognitively healthy samples (the
norm sample in red, the validation sample in blue), as well as in individ-
uals withMCI and dementia (in shades of green)
4 DISCUSSION
Based on assessments from 3088 cognitively normal Dutch adults, we
established a regression-based formula to calculate demographically
adjusted, standardized norm scores for the Cognitive Online Self-Test
Amsterdam (orCOST-A).We then used this formula to calculate demo-
graphically adjusted norm scores in 2440 community-dwelling adults.
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F IGURE 2 Demographically adjusted norm scores for COST-A, stratified by sample and diagnosis. The vertical line represents the
predetermined cutoff of−1.5 SD
In both samples, approximately 8% of participants scored below the
cutoff, illustrating the robustness of our norm formula. When applying
the norm formula to a clinical sample, 75% of MCI patients and 82%
of dementia patients had abnormal demographically adjusted norm
scores. The cutoff was also confirmed to distinguish cognitively nor-
mal from cognitively abnormal individuals (MCI or dementia) with high
accuracy. As such, COST-A may serve as a screening tool to identify
those individuals who require formal assessment by a health care pro-
fessional and/or for research studies.
Most individuals who completed COST-A evaluated the test pos-
itively. Test completion took less than 20 minutes, which the large
majority of participants judged to be acceptable. Of note, approxi-
mately 10%of cognitively normal participantswho startedCOST-Adid
not successfully complete all tasks. This percentage was lower than
in some smartphone-based assessments21,22 and another online self-
test,12 but higher than in an online cognitive assessment tool that
was framed as a game.23 Participants who were unable to complete
COST-A, and who were therefore excluded, were older than partic-
ipants who did complete it. Still, our norm sample comprised suffi-
cient numbers of older adults, up to 96 years of age, demonstrating
feasibility of online self-administration of cognitive tests among the
elderly.
As expected, and in accordance with previous findings,24–26 older
age and a lower education level significantly predicted lower cogni-
tive functioning as measured with COST-A. In our norm sample, we
found that men performed worse than women. Previous studies have
shown both better and worse cognitive performance in men,24 and
further exploration of these gender differences is thus an interesting
direction for future research. Based on our findings, an adjustment
for these demographic characteristics is warranted. The demograph-
ically adjusted norm scores thus represent the normalized difference
between expected and actual performance on COST-A for a given indi-
vidual. Following standard practice,24 a norm score thatwasmore than
1.5 SD below themeanwas predetermined to represent abnormal per-
formance. Our findings corroborated this cutoff, as it was also the opti-
mal value to distinguish between cognitively normal individuals and
those withMCI or dementia.
A few factors may impede the interpretation of COST-A results
at the individual level. First, a proportion of participants reported to
have been interrupted during the test, which can occur in the home
environment. Although such interruption might negatively influence
an individual’s score, our results show that this does not necessar-
ily result in an abnormal norm score. When considering any kind
of encountered difficulties, including problems with the keyboard or
vision, individuals’ chances to score below the cutoff increased. This
could, however, be a case of reverse causality, that is, we cannot dis-
cern whether these problems caused a lower test score, or whether
thosewho havemore cognitive problems encounteredmore problems.
To resolve this issue of reverse causality, future research could invite
participantswho reporteddifficultieswhen completingCOST-Aduring
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self-administration at home for a face-to-face neuropsychological
assessment in a more controlled environment, to allow comparison
of performance between methods. Nevertheless, it is important to be
mindful of the potential influence of self-reported encountered diffi-
culties when interpreting an individual’s result.
Second, we found that participantswithmore depressive symptoms
performworseandmoreoften scorebelowthe cutoff,which is in accor-
dancewith previous research showing that individuals with depressive
symptomshavepoorer cognitive performance.2728 In addition, approx-
imately half of our cognitively healthy participants reported memory
complaints. This high numbermay, in part, be becausewe asked partici-
pantswhether theyexperiencedmemory complaints immediately after
completingCOST-A. Still, participantswho self-reportedmemory com-
plaints, indeed had lower COST-A scores and were more likely to fall
below the cutoff than participants who did not. For many, their subjec-
tive experience did thus match their objective performance. However,
only one in five individuals who reported memory complaints actually
scoredbelow the cutoff. This emphasizes the importanceof a short cog-
nitive screening such as COST-A, as it can help to underscore or refute
subjective cognitive complaints in comparison to others. Overall, at-
home assessment seems feasible for many, including the elderly and
participants with a low to medium level of education, if the aforemen-
tioned factors are consideredwhen interpreting and disclosing an indi-
vidual’s score.
Online testing is now increasingly applied in both clinical practice
and research.29,30 It has numerous benefits over in-person testing,
including the possibility for remote assessment. This is especially rele-
vant in light of theCOVID-19pandemic,which has forcedmany studies
to resort to alternative forms of cognitive testing. Even when govern-
ment restrictions are eventually lifted, online testing will allow those
who are unable to visit a memory clinic or research site to be tested
remotely. In addition, it may facilitate follow-up of patients and par-
ticipants over time by reducing the barrier of travel to the clinic or
research site every time.
We do not consider an online self-test such as COST-A to be
a replacement for other diagnostic tests such as those provided in
a memory clinic. Nevertheless, with the evidence we present here,
COST-A may play an important role in the diagnostic process for neu-
rodegenerative diseases as a pre-screener. When an individual wor-
ries about their cognitive functioning, they could complete COST-A at
home. When their COST-A score falls within the expected range, this
might serve as reassurance. When it is below the cutoff, the individual
could be encouraged to visit their general practitioner, who can refer
them to a memory clinic if deemed appropriate. Furthermore, in the
future, it is conceivable that COST-A may be combined with relatively
low-invasivebloodbiomarker testing toperformpre-screening for clin-
ical trials of disease-modifying drugs, as these are increasingly aimed at
the earliest disease stages.31
This study had some limitations.Wedid not performmore extensive
neuropsychological testing of the cognitively normal individuals, and as
such it is possible that we may have included people with undiagnosed
cognitive impairment in these samples. To reduce the influenceof these
potential cases, we removed individuals with COST-A scores of more
than 3 SD below the mean. In addition, because assessment was com-
pletely remote,we could not control the environment inwhichCOST-A
was completed, including test conditions and thedevice used. Although
this may have introduced some noise into our data, we do believe this
more accurately reflects the home environment in which the test may
eventually be administered.
An important strength of this study was the inclusion of two large
sets of cognitively normal individuals across a wide age range, pro-
viding an adequate representation of the Dutch adult population. This
means that the norm-score formula can be applied broadly to bothmen
andwomen of varying ages and education levels. Another strengthwas
the inclusion of a clinical sample to obtain details about the discrim-
inatory ability of COST-A. This sample included individuals with MCI
and dementia, and their performancewasmarkedly lower, proving that
COST-A can be used to distinguish between cognitively normal and
abnormal. Furthermore, we included an appraisal of participants user
experience of COST-A, going beyond frequently reported measures
such as compliance and completion rates.
This study provides many opportunities for future research. To fur-
ther develop a test result report, including explanatory texts and visu-
als, we envision a qualitative study involving all stakeholders. This
result report should counsel individuals in their interpretation of the
results, and give advice on whether or not to visit a general practi-
tioner based on the results. Then, the impact of implementing COST-
A should be piloted and investigated in clinical practice, for example,
the primary care setting, and the possibility of administering COST-A
onmobile devices should be investigated. Finally, test-retest reliability
as well as the predictive quality and usability of COST-A for the mea-
surement of disease progression should be investigated in longitudinal
studies.
In conclusion, we established a formula to obtain demographically
adjusted norm scores for COST-A, a brief online self-test, and subse-
quently showed that these norms are robust across populations. As
such, COST-A is a promising new tool for clinical and research practice,
providing low-cost andminimally invasive remote assessment of cogni-
tive functioning.
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